Drawing for SYNTHON

USPTO serial 87464096

SYNTHON

Reviewed by CopyMark Law Group

Reg. 5923742Status 701Registered
Filing date
Status date
Registration date
Dec 3, 2019
Examiner
AYALA, LOURDES
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with SYNTHON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

E. Anthony Figg

E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC901 New York Avenue, NWSuite 900 EastWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS, SUBSTANCES AND COMPOSITIONS FOR THE TREATMENT OF CANCER, MULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERS, CARDIOVASCULAR DISORDERS, METABOLIC AND GASTRIC DISORDERS, BLOOD DISORDERS, BONE DISORDERS, HORMONAL DISORDERS, TREATMENT OF PAIN, FUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIA; BIOLOGICAL AND BIOCHEMICAL DRUG AND CULTURES FOR MEDICAL USE, NAMELY, BIOLOGICAL TISSUE CULTURES FOR MEDICAL PURPOSES; CULTURE FLUIDS FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR CULTIVATING HUMAN, AND ANIMAL CELLS AND PLANTS, PLANT CELLS AND PLANT TISSUES; CULTURE MEDIA FOR USE IN CULTURING EUKARYOTIC CELLS; PHARMACEUTICAL BIOLOGICAL AND BIOCHEMICAL DRUGS FOR THE TREATMENT OF NEOPLASMS AND AUTOIMMUNE DISEASEACTIVE—
035OFFICE FUNCTIONS RELATING TO THE REGISTRATION OF PHARMACEUTICAL PREPARATIONS AND COMPONENTS AND PHARMACEUTICAL DRUGS; OFFICE FUNCTIONS RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; BUSINESS MEDIATION OF AGREEMENTS REGARDING THE PURCHASE, SALE AND LICENSING OF PHARMACEUTICAL REGISTRATIONS AND PHARMACEUTICAL REGISTRATION DOSSIERS; BUSINESS ADVICE AND INFORMATION; BUSINESS CONSULTATION; PROCUREMENT OF CONTRACTS FOR OTHERS FOR THE PURCHASE AND SALE OF GOODS; BUSINESS SERVICES, NAMELY, COMPILING OF PHARMACEUTICAL REGISTRATION DOSSIERS FOR OTHERSACTIVE—
040TREATMENT OF MATERIALS FOR THE MANUFACTURE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS; MANUFACTURE, FOR OTHERS, OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS AND RAW MATERIALS FOR THE PHARMACEUTICAL INDUSTRY, ALL IN THE FIELD OF TREATMENT OF CANCER, MULTIPLE SCLEROSIS AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM, NEOPLASMS AND AUTOIMMUNE DISEASES AND THOSE INTENDED FOR THE TREATMENT OF KIDNEY AND GENITOURINARY DISORDERS, CARDIOVASCULAR DISORDERS, METABOLIC AND GASTRIC DISORDERS, BLOOD DISORDERS, BONE DISORDERS, HORMONAL DISORDERS, TREATMENT OF PAIN, FUNGAL AND BACTERIAL DISEASES AND PREPARATIONS USED IN THE MANAGEMENT OF ANESTHESIAACTIVE—
045LEGAL SERVICES RELATING TO OBTAINING PHARMACEUTICAL REGISTRATIONS AND COMPILING PHARMACEUTICAL REGISTRATION FILES; PROVIDING LEGAL SERVICES AND INFORMATION IN THE FIELD OF INTELLECTUAL PROPERTY; LEGAL ADVICE IN THE FIELD OF INTELLECTUAL PROPERTYACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 6, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Apr 6, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Apr 6, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 21, 2025ES8RTEAS SECTION 8 RECEIVED—
Dec 3, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 30, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Oct 30, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 23, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 17, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 17, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Sep 16, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 3, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2019ALIEASSIGNED TO LIE—
May 21, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 21, 2019XAECEXAMINER'S AMENDMENT ENTERED—
May 21, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 21, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
May 21, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2019EXPTEXPARTE APPEAL TERMINATED—
Feb 14, 2019EXAREXPARTE APPEAL AFFIRMED/REVERSED IN PART—
Jul 20, 2018GNSNNOTIFICATION OF EXAMINERS STATEMENT E-MAILED—
Jul 20, 2018GNESEXAMINERS STATEMENT E-MAILED—
Jul 20, 2018CNESEXAMINERS STATEMENT - COMPLETED—
May 31, 2018JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Mar 23, 2018EXPIEX PARTE APPEAL-INSTITUTED—
Mar 23, 2018EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jan 25, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 25, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 25, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 22, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 22, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 22, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2017DOCKASSIGNED TO EXAMINER—
Jun 1, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance